Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial-Reference-Cited by-同舟云学术

Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial

Published:2017-10-19 Issue:5 Volume:179 Page:748-755
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Nozza Andrea¹^ORCID,Terenghi Fabrizia²,Gallia Francesca²,Adami Fausto³,Briani Chiara⁴,Merlini Giampaolo⁵,Giordano Laura⁶,Santoro Armando¹⁷,Nobile-Orazio Eduardo²

Affiliation:

1. Department of Medical Oncology and Haematology; Humanitas Cancer Centre; Humanitas Clinical and Research Hospital IRCCS; Milan Italy

2. Neuromuscular and Neuroimmunology Service; Department of Medical Biotechnology and Translational Medicine; Milan University; Humanitas Clinical and Research Hospital IRCCS; Milan Italy

3. Department of Medicine - Haematology & Clinical Immunology Section; University of Padova; Padua Italy

4. Department of Neurosciences; University of Padova; Padova Italy

5. Amyloidosis Research and Treatment Centre, Foundation “Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo”; Department of Molecular Medicine; University of Pavia; Pavia Italy

6. Biostatistic Unit; Humanitas Cancer Centre; Humanitas Clinical and Research Hospital IRCCS; Milan Italy

7. Humanitas University; Milan Italy

Funder

Celgene

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14966/fullpdf

Reference25 articles.

1. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature;Bardwick;Medicine (Baltimore),1980